The Clinical and Research Updates section monitors drug and data across India's pharmaceutical sector. Significant developments around phase continue to draw attention from regulators, investors, and industry professionals, reflecting the dynamic pace of change in this space.
Recent coverage has drawn from The Manila Times, Revista Merca2.0, and Quiver Quantitative, among other publications. This section is updated as new stories emerge, ensuring readers have access to the most current information shaping this part of the pharmaceutical landscape.
For authoritative reference, World Health Organisation and CDSCO publish official guidance and regulatory documentation relevant to these topics. Peer-reviewed research and clinical data can be accessed through PharmaBiz.
Showing 30 articles
-
New data from Phase 2 ZUPREME-1 trial at the American Diabetes Association 2026 Scientific Sessions further support potential of petrelintide to redefine the weight management experience for people living with overweight and obesity
New data from Phase 2 ZUPREME-1 trial at the American Diabetes Association 2026 Scientific Sessions further support potential of petrelintide to redefine the weight management experience for people living with overweight and obesity The Manila Times
-
Historic breakthrough in diabetes treatment: scientists take steps toward a fat-burning pill without the side effects of Ozempic
Historic breakthrough in diabetes treatment: scientists take steps toward a fat-burning pill without the side effects of Ozempic Revista Merca2.0
-
Structure Therapeutics Inc. Releases Positive Phase 2b Data for Aleniglipron at ADA’s 86th Scientific Sessions, Highlighting Significant Weight Loss and Favorable Tolerability
Structure Therapeutics Inc. Releases Positive Phase 2b Data for Aleniglipron at ADA’s 86th Scientific Sessions, Highlighting Significant Weight Loss and Favorable Tolerability Quiver Quantitative
-
Oral obesity drug helped people lose up to 16% body weight in trial
Oral obesity drug helped people lose up to 16% body weight in trial Stock Titan
-
Winning the lottery with a clinical trial to treat pancreatic cancer
Winning the lottery with a clinical trial to treat pancreatic cancer UCLA Health
-
Altesa BioSciences Presents New Phase 2 Vapendavir Challenge Study Results at 2026 American Society for Microbiology (ASM) Microbe Conference
Altesa BioSciences Presents New Phase 2 Vapendavir Challenge Study Results at 2026 American Society for Microbiology (ASM) Microbe Conference The Malaysian Reserve
-
Mount Saint Joseph Hospital Phase 1 Clinical Trials in B.C.
Mount Saint Joseph Hospital Phase 1 Clinical Trials in B.C. The Daily Scan
-
Genetic Variants Linked to Resistance to Diabetes Drug GLP-1
Genetic Variants Linked to Resistance to Diabetes Drug GLP-1 SSBCrack
-
Study data convince Lundbeck to push new migraine drug forward
Study data convince Lundbeck to push new migraine drug forward BioPharma Dive
-
EyeWorld Weekly, June 5, 2026
EyeWorld Weekly, June 5, 2026 EyeWorld
-
Scientists discover why ozempic may not work for some people
Scientists discover why ozempic may not work for some people ScienceDaily
-
Off‑label prescribing rampant in paediatrics as clinical trials for children lag behind
Off‑label prescribing rampant in paediatrics as clinical trials for children lag behind Новости GxP
-
Pediatric clinical trials update: May 2026
Pediatric clinical trials update: May 2026 Contemporary Pediatrics
-
New targeted therapy shrinks advanced gastrointestinal tumours for 61 per cent of patients in an early study
New targeted therapy shrinks advanced gastrointestinal tumours for 61 per cent of patients in an early study The Institute of Cancer Research (ICR)
-
Maternal RSV vaccine cuts infant hospitalizations by 70%, study shows
Maternal RSV vaccine cuts infant hospitalizations by 70%, study shows Medical Xpress
-
Two Common IV Fluids Perform Equally Well for Treating Septic Shock in Kids | Newswise
Two Common IV Fluids Perform Equally Well for Treating Septic Shock in Kids | Newswise Newswise
-
Toxicity, Censoring, and the Limits of Trial Reporting
Toxicity, Censoring, and the Limits of Trial Reporting Medscape
-
Immunotherapy injection shrinks tumours in patients with recurrent and/or metastatic head and neck cancer
Immunotherapy injection shrinks tumours in patients with recurrent and/or metastatic head and neck cancer The Institute of Cancer Research (ICR)
-
Targeted therapy shows promise for patients with advanced colorectal cancer in a first-in-human study
Targeted therapy shows promise for patients with advanced colorectal cancer in a first-in-human study The Institute of Cancer Research (ICR)
-
Experimental drug for pancreatic cancer based on UC research offers new hope
Experimental drug for pancreatic cancer based on UC research offers new hope University of California
-
Chronic Kidney Disease to become leading cause of premature death by 2040: Studies
Chronic Kidney Disease to become leading cause of premature death by 2040: Studies The New Indian Express
-
Finerenone expands promise beyond diabetic kidney disease
Finerenone expands promise beyond diabetic kidney disease Indian Pharma Post
-
Experimental drug combination shows early effectiveness in advanced kidney cancer
Experimental drug combination shows early effectiveness in advanced kidney cancer Medical Xpress
-
Beyond average-based medicine: HIE as a blueprint for data-informed care
Beyond average-based medicine: HIE as a blueprint for data-informed care Boston Children's Answers
-
Blood Pressure Drug Linked to Worse Kidney Outcomes in T2D: ERA 2026
Blood Pressure Drug Linked to Worse Kidney Outcomes in T2D: ERA 2026 EMJ
-
Immutep (IMMP) posts positive first-in-human Phase I data for IMP761
Immutep (IMMP) posts positive first-in-human Phase I data for IMP761 Stock Titan
-
Kidney drug finerenone may help millions more patients after three major studies
Kidney drug finerenone may help millions more patients after three major studies Medical Xpress
-
The Evolution of Artificial Intelligence in Oncology: Impact on Trials, Workflows, and Outcomes
The Evolution of Artificial Intelligence in Oncology: Impact on Trials, Workflows, and Outcomes CancerNetwork
-
New Daily Pill Shows Potential Against Alzheimer’s and Parkinson’s Disease
New Daily Pill Shows Potential Against Alzheimer’s and Parkinson’s Disease The CSR Journal
-
Commentary: Big medical breakthroughs start with small gains — Sally C. Pipes
Commentary: Big medical breakthroughs start with small gains — Sally C. Pipes Jacksonville Journal-Courier